Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,833,053
+$693,668 QoQ
Shares Held
2,362
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.84%
of 13F equity value
Holder Rank
#2,182
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traveka Wealth, LLC holds $7,683,360 across 9 Drug Manufacturers - General names. LLY ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,362 | $2,833,053 | |
| 2 | JNJ |
Johnson & Johnson
|
6,397 | $1,624,646 | |
| 3 | ABBV |
AbbVie Inc.
|
3,731 | $938,868 | |
| 4 | AZN |
Astrazeneca PLC
|
3,416 | $647,741 | |
| 5 | NVS |
Novartis AG
|
3,165 | $496,018 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,711 | $348,363 | |
| 7 | AMGN |
Amgen Inc
|
926 | $335,323 | |
| 8 | NVO |
Novo Nordisk A S
|
5,265 | $252,404 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,833,053 | 2,362 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,139,385 | 2,326 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $2,471,764 | 2,300 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,832,726 | 2,402 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,903,612 | 2,442 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,139,106 | 2,590 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,022,380 | 3,915 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,393,809 | 2,702 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $2,851,041 | 3,149 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $2,362,664 | 3,037 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,436,605 | 4,180 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||